Tag: Clinical Trials
Patient Enrollment in Cancer Treatment Trials About 7 Percent
One in five patients with cancer participate in any cancer-related trial, including biorepository, registry, genetic, and quality-of-life studies
Biological Agent Trials for Psoriasis Rarely Include Patient Images
A total of 203 images were shared depicting 60 patients, for an overall sharing rate of 0.1 percent
White Women Overrepresented in Gynecologic Cancer Trials
Underrepresentation seen among Asian and Hispanic women for all cancer sites, with variance for Black women by cancer site
Diversity in Early-Phase Cancer Trials Improved Since 2000
Some gains seen in racial/ethnic and geographic diversity; more older patients also enrolled
Survival Similar for Black, White Prostate Cancer Patients in Clinical Trial Setting
Median PFS, OS similar for Black and White patients receiving first- or second-generation androgen receptor pathway inhibitors
Eligibility Criteria May Influence Disparity in Multiple Myeloma Trial Enrollment
Blacks and other race subgroups have higher multiple myeloma trial ineligibility rates compared with Whites
Race, Ethnicity Reporting in Pediatric Clinical Trials Has Improved
Asian American, Black, and Hispanic populations underrepresented compared with U.S. population demographics
Outcomes Worse for Black Patients With Head, Neck Cancer in Clinical Trials
Outcomes worse for Black versus White patients enrolled in clinical trials that minimize access to care, socioeconomic status confounders
Females, Some Minorities Underrepresented in COVID-19 Clinical Trials
Females underrepresented in treatment trials, while Asian, Black participants underrepresented in prevention trials
Preprint, Peer-Reviewed Pairs of Studies Generally Concordant
Sample sizes, primary end points, interpretations mainly concordant for studies published on medRxiv, then in journals
